Search results
The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward


In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials...Read more

Justin McCarthy
SVP Global Policy and International Public Affairs, Pfizer Inc., USA
Marc Wilenzick
Chief Compliance Counsel, R&D, Pfizer Inc, USA
Cara Cuenot
Lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA
Left to Their Own Devices
The European Union (“EU”) has among its most fundamental goals and principles a convergence of the economies of, and a weakening of internal frontiers between, its member states. Economic...Read more

Patrik Plöen
Head of Legal, Internationa, Markets, Nestlé Skin Health, Sweden
More Than Words: Reflections of a General Counsel
As we approach the second decade of the 21st century, general counsel have a unique opportunity to pause and reflect. We began the previous decade with a stock market crash...Read more
Hassan Hassan
Associate General Counsel, Mars, UAE
Standing The Test of Time: Important Considerations in Long-Term Partnering Transactions

In the integrated global economy that has emerged over the last two decades, companies in all industries require a network of partners to discover, develop, manufacture, market, sell, supply and...Read more
Frank Curtis
Vice President-legal Commercial and Regulatory, Nektar Therapeutics, USA
Gilbert Labrucherie
Senior Vice President and General Counsel, Nektar Therapeutics, USA
Enlightening The Jungle: The German Rules on Advertising Pharmaceuticals
The legal rules applying to advertising medicines in Germany resemble a jungle. While a Medical Products Advertising Act (hereafter the Act) has been put in place, which concentrates on rules...Read more
Thorsten Witt
Corporate Counsel, Celesio, Germany
An Effective, Practical Approach to International Competition Law Compliance
The traditional approach to antitrust or competition law compliance is to start with the parade of horribles that can flow from a violation (jail, fines, damages, bad press), then stress...Read more

Kent Bernard
Member, Bar of the Commonwealth of Pennsylvania, U.S.A., Kent Bernard, USA
How Much Value is Your Company Losing? Implementing Effective Intellectual Property Management
Increasingly most of the value of a company today can be attributed to its intellectual property and other intangible assets. Without effective management of these assets, including governance committees, intellectual...Read more

Gunnar Wieboldt
General Counsel & VP of Corporate Development, Wearality Corporation, USA
United States Jurisdiction Abroad
The United States applies their jurisdiction abroad under several instances. This is something very important for U.S. based corporations with global operations to understand, since there might be in a...Read more

Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Different Approaches to Pricing and Reimbursement of Innovative Pharmaceutical Products in Europe
All aspects of the pharmaceutical market are heavily regulated due to the major public health implications related to the use of pharmaceutical products.
Pricing and reimbursement of pharmaceutical products is...Read more
Renato Dellamano
President, Value Vector, Italy